| Literature DB >> 36206464 |
Clive Wasserfall1, Anne-Marie Dyer2, Cate Speake3, Dana K Andersen4, Kendall Thomas Baab2, Melena D Bellin, James R Broach5, Martha Campbell-Thompson1, Vernon M Chinchilli2, Peter J Lee6, Walter G Park7, Richard E Pratley8, Jami L Saloman9, Emily K Sims10, Gong Tang11, Dhiraj Yadav, Cemal Yazici12, Darwin L Conwell6.
Abstract
ABSTRACT: Differences in methods for biospecimen collection, processing, and storage can yield considerable variability and error. Therefore, best practices for standard operating procedures are critical for successful discovery, development, and validation of disease biomarkers. Here, we describe standard operating procedures developed for biospecimen collection during the DREAM (Diabetes RElated to Acute pancreatitis and its Mechanisms) Study within the Type 1 Diabetes in Acute Pancreatitis Consortium. Notably, these protocols were developed using an integrative process based on prior consortium experience and with input from working groups with expertise in immunology, pancreatitis, and diabetes. Publication and adoption consistent biospecimen protocols will inform future studies and allow for better comparisons across different metabolic research efforts.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36206464 PMCID: PMC9555853 DOI: 10.1097/MPA.0000000000002077
Source DB: PubMed Journal: Pancreas ISSN: 0885-3177 Impact factor: 3.243